| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c684df17c1e09127a3765f1138203f85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adb0e564374fedf34b36103d36e6455a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_633e96b87dc01751b8262dc8b333d3f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aae90b954513879a5a2180a16706594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a309962fb0fbfb376fb5d0a50b083a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ce997461fc1226bbd4b17679857e88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1248b7f9f1bcd2096999aaf4b0ed990c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4cbf71bc54634e2fe6cbb76a0914a19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eff9af10472491f56778705a368eff6 |
| publicationDate |
2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020161088-A1 |
| titleOfInvention |
Therapeutic combinations and compositions for the treatment of inflammatory bowel disease |
| abstract |
The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin. |
| priorityDate |
2019-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |